Write a short note on nsaids in orthopedics
I'll start by reading the medical library skill, then search for relevant NSAID content in orthopedics.
Reading File
Now let me search the library and PubMed in parallel.
Finding Sources
Finding Sources
Searching PubMed
NSAIDs orthopedic surgery bone healing fracture
Let me search more broadly in the textbook library.
Finding Sources
Finding Sources
Reading Article
PMID: 39319252
Now let me pull content from the Rockwood and Green's fractures textbook which had directly relevant content.
Finding Sources
Finding Sources
Reading File
Finding Sources
Now let me read the Campbell's HO and perioperative NSAID sections for full content.
Reading File
Reading File
I now have excellent content from Campbell's Operative Orthopaedics and Barash Clinical Anesthesia, plus the 2024 meta-analysis. Let me compile the full note.
NSAIDs in Orthopedics
Classification
NSAIDs are classified by their selectivity for COX enzymes:
| Class | Examples |
|---|---|
| Non-selective (COX-1 + COX-2) | Ibuprofen, diclofenac, naproxen, indomethacin, ketorolac |
| COX-2 preferential | Meloxicam (IV meloxicam approved by FDA in 2020) |
| COX-2 selective (coxibs) | Celecoxib |
Mechanism of Action
NSAIDs inhibit cyclooxygenase (COX-1 and COX-2) enzymes, which convert arachidonic acid to prostaglandin H2 (PGH2). This reduces prostaglandin-mediated inflammation, pain sensitization, and pyrexia. They act by binding the COX site on the COX enzyme. This same pathway - prostaglandin synthesis - also governs osteoblast/osteoclast activity, angiogenesis, and callus formation, which explains why NSAIDs have complex effects on bone biology. - Barash Clinical Anesthesia, 9e
Roles in Orthopedic Practice
1. Perioperative / Post-Operative Analgesia
NSAIDs are a cornerstone of multimodal analgesia in orthopedic surgery. They are opioid-sparing and reduce pain after fracture fixation, joint arthroplasty, and spine surgery. Combining an NSAID with acetaminophen produces superior analgesia to either agent alone.
- IV ketorolac is widely used for short-term post-op pain.
- IV meloxicam (30-60 mg once daily) was FDA-approved in 2020 for perioperative pain; its COX-2 preferential action reduces platelet effects vs. non-selective agents.
- Celecoxib (loading dose 400 mg then 200 mg q12h orally) is the only COX-2-specific inhibitor currently available in the US for post-op pain, after rofecoxib and valdecoxib were withdrawn due to cardiovascular concerns. - Barash Clinical Anesthesia, 9e
2. Heterotopic Ossification (HO) Prophylaxis
This is one of the most well-established orthopedic uses of NSAIDs:
- Indomethacin (25 mg TDS for 6 weeks) is the classic NSAID used for HO prophylaxis following:
- Total hip arthroplasty (THA)
- Acetabular fracture surgery
- Elbow trauma surgery
- It works by inhibiting prostaglandin-driven differentiation of mesenchymal stem cells into osteoblasts.
- Alternative to indomethacin: low-dose radiation (single dose 700-800 cGy within 72 hours).
- Caution: Indomethacin prophylaxis for HO has been associated with an increased risk of long-bone non-union in some studies. - Campbell's Operative Orthopaedics, 15th Ed 2026
3. Chronic Musculoskeletal Pain
NSAIDs are first-line or adjunct therapy for:
- Osteoarthritis (OA) of hip, knee, and spine
- Rheumatoid arthritis and spondyloarthropathies
- Acute soft tissue injuries, tendinopathies, and bursitis
- Paget's disease of bone (with calcitonin and bisphosphonates) - Adams & Victor's Principles of Neurology, 12e
Effects on Bone Healing - A Key Controversy
This is arguably the most debated topic regarding NSAIDs in orthopedics:
Concern: Prostaglandins (PGE2 in particular) play a key role in fracture healing - stimulating angiogenesis, callus formation, and osteoblast differentiation. COX inhibition theoretically impairs this process.
Evidence:
- Animal studies (particularly rodent models) showed delayed or impaired fracture union with NSAIDs.
- A 2024 systematic review and meta-analysis of 20 studies (n = 523,240 patients) found no statistically significant difference in non-union or delayed union between NSAID users and non-users (pooled adjusted OR = 1.11; 95% CI: 0.99-1.23). An initial association with reoperation risk became non-significant on sensitivity analysis. However, the authors cautioned that specific NSAID types and dosages were not controlled for. - [Chuang et al., 2024, Frontiers in Endocrinology, PMID 39319252]
- The effect of COX-2-selective inhibitors on bone fusion following orthopedic procedures remains controversial; no firm recommendations can be made. Traditional NSAIDs have shown inhibition particularly of lumbar spinal fusion. - Barash Clinical Anesthesia, 9e
Practical guidance:
- Short-term peri-operative use (e.g., 3-5 days) is considered safer than prolonged use.
- Avoid prolonged NSAID use in patients at high non-union risk (comminuted fractures, smokers, osteoporotic bone, spinal fusion).
- If HO prophylaxis with indomethacin is given, weigh the HO risk vs. non-union risk - especially when there is concomitant long-bone fracture.
Adverse Effects Relevant to Orthopedics
| Side Effect | Clinical Relevance |
|---|---|
| Platelet dysfunction (COX-1 inhibition) | Increased perioperative bleeding; non-selective NSAIDs are typically stopped 5-7 days pre-op (COX-2 inhibitors have minimal platelet effect) |
| GI ulceration | Especially in elderly post-arthroplasty patients on NSAIDs long-term; use PPI cover |
| Nephrotoxicity | High risk in hypovolemia, heart failure, renal insufficiency - common post-op states |
| Fluid retention/hypertension | Both non-selective and COX-2 inhibitors affect renal prostaglandins |
| Cardiovascular risk | COX-2 inhibitors (esp. rofecoxib - now withdrawn): avoid in CAD/CVD patients |
| Bone healing impairment | Especially with prolonged use; avoid in spinal fusion and high non-union risk fractures |
- Barash Clinical Anesthesia, 9e
Special Considerations
- Elderly patients (e.g., hip fracture): A 2024 systematic review on NSAIDs for perioperative pain in hip fracture surgery found evidence for analgesic efficacy but called for caution given renal risk and drug interactions in this population. - [Pommier et al., 2024, Drugs & Aging, PMID 37880500]
- Children: Avoid aspirin (Reye's syndrome risk under 12 years).
- Pre-operative continuation: COX-2 inhibitors (celecoxib) may be continued until the morning of surgery without increasing bleeding risk, unlike non-selective NSAIDs.
Summary
NSAIDs occupy a central place in orthopedic practice: for acute perioperative analgesia, chronic musculoskeletal pain, and HO prophylaxis. Their main orthopedic-specific concern - impairment of bone healing - appears less significant clinically than animal models suggested, but caution remains warranted with prolonged use in fractures and spinal fusion. COX-2 selective agents offer GI and platelet safety advantages but carry cardiovascular risk. Individualized risk-benefit assessment guides their use.
This is a shared conversation. Sign in to Orris to start your own chat.